Weight Loss Drugs Panel
As Ozempic, Wegovy, Mounjaro and other injectable diabetes and weight-loss medications continue to make headlines for the successes and challenges many see with the medications for obesity and metabolic conditions, questions — regarding impacts on pregnant persons, potential uses for other medical conditions, concerns over counterfeit products that have flooded the market, discussions over what these mean for those with histories of disordered eating and more — continue to emerge.
On Monday, March 18, 2024, experts from the University of Maryland, Baltimore (UMB) met with members of the press for a virtual press briefing to discuss these topics and more. UMB’s renowned experts from its Schools of Medicine, Pharmacy, and Social Work provided important updates and insights on various aspects of these medications and their impact on patients.This panel discussion includes:• Experts from University of Maryland Baltimore discuss various medications and their effects• Discussion on the limitations of previous weight loss medications and their side effects• Explanation of how GLP-1 agonists work to control blood glucose levels and decrease hunger• Emphasis on the importance of treating obesity as a chronic disease and the benefits of doing so
More from Youtube
- 4:24UMB's 13th Annual Interprofessional Education DayHosted by the University of Maryland Baltimore's Center for Interprofessional Education (CIPE) on April 2, IPE Day brought together more than 170 students from all seven UMB professional schools — including medicine, nursing, pharmacy, law, dentistry, physical therapy, social work, and the Graduate School — for a full afternoon of collaborative learning, simulation activities, and real-life insights into the power of team-based care.Read more: https://www.umaryland.edu/news/archived-news/april-2025/ipe-day-centers-on-listening-to-patients-and-peers.php
- 59:34Virtual Face to Face: The Challenges Facing Academic ResearchThe changes and challenges facing academic research and the University of Maryland, Baltimore's response was the topic of Virtual Face to Face on April 10 hosted by James Hughes, MBA, Chief Enterprise and Economic Development Officer and Senior Vice President. Hughes was joined by University of Maryland School of Medicine Professor and Executive Vice Dean Chris O’Donnell, PhD, and E. Albert Reece, MD, PhD, MBA, Director of the Center for Advanced Research Training and Innovation.